More Globe Newswire

View Older Stories View Newer Stories

Oct 30, 2024 08:00AM NUMERATOR ANNOUNCES 200,000 PANEL WITH NEW TRANSPARENCY STANDARD
Oct 30, 2024 08:00AM ASP Isotopes Inc. to Present at the Emerging Growth Conference on Wednesday, October 30, 2024
Oct 30, 2024 08:00AM ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
Oct 30, 2024 08:00AM Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Oct 30, 2024 08:00AM Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
Oct 30, 2024 08:00AM Kalsec Publishes “Beyond the Burn” Survey Findings, Highlighting Consumer Preferences for Spicy Foods
Oct 30, 2024 08:00AM Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
Oct 30, 2024 08:00AM LaunchDarkly Launches Dedicated EU Region to Support EU Data Residency and Compliance Needs
Oct 30, 2024 08:00AM Brera Holdings Provides Update on Women’s Football Club Brera Tiverija’s Outstanding Season
Oct 30, 2024 08:00AM Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference
Oct 30, 2024 08:00AM PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
Oct 30, 2024 08:00AM MOOG® Unveils New Constant Velocity Axles
Oct 30, 2024 08:00AM Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024
Oct 30, 2024 08:00AM Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors
Oct 30, 2024 07:58AM Form 8.3 - Balanced Commercial Property Trust Limited
Oct 30, 2024 07:57AM Director/PDMR Shareholding
Oct 30, 2024 07:45AM Industry Leader Clearlight® Honors Service with Exclusive Veterans Day Offer
Oct 30, 2024 07:40AM Jeffs' Brands Enters Into a Non-Binding Letter of Intent for the Sale of its U.S. Subsidiary to a U.S. Public Company, at a valuation of approximately $13.125 million
Oct 30, 2024 07:40AM Jeffs' Brands Enters Into a Non-Binding Letter of Intent for the Sale of its U.S. Subsidiary to a U.S. Public Company, at a valuation of approximately $13.125 million
Oct 30, 2024 07:31AM Mattr to Present and Host 1x1 Investor Meetings at the 16th Annual Southwest Ideas Investor Conference on November 20th in Dallas, TX
Oct 30, 2024 07:30AM Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
Oct 30, 2024 07:30AM TC Energy lists Series 10 Preferred Shares
Oct 30, 2024 07:30AM InspireSemi Announces Annual General and Special Meeting and Appointment of Director
Oct 30, 2024 07:30AM Midland Identifies Copper-Gold-Molybdenum-Silver Occurrences on the Saruman Project
Oct 30, 2024 07:30AM Amerigo Announces Q3-2024 Results & Quarterly Dividend
Oct 30, 2024 07:30AM CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
Oct 30, 2024 07:30AM Stock Yards Bancorp to Participate in the 2024 Hovde Group Financial Services Conference
Oct 30, 2024 07:30AM MariMed Commences Manufacturing Operations in Missouri
Oct 30, 2024 07:30AM HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
Oct 30, 2024 07:30AM DeFi Technologies' Subsidiary Valour Expands Offerings with First-Ever Valour Bittensor (TAO) SEK ETP in the Nordics on Spotlight Stock Market
Oct 30, 2024 07:30AM Brixton Metals Releases Additional High-Grade Gold Assays From its Exciting Trapper Gold Target on its Wholly Owned Thorn Project
Oct 30, 2024 07:30AM Amerigo Announces Q3-2024 Results & Quarterly Dividend
Oct 30, 2024 07:30AM HydroGraph and the GEIC Proudly Extend Research Partnership
Oct 30, 2024 07:30AM HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
Oct 30, 2024 07:30AM Safe Harbor Financial to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
Oct 30, 2024 07:30AM MacroGenics Announces Leadership Transition
Oct 30, 2024 07:26AM EAACI Unveils Groundbreaking Guidelines for IgE-Mediated Food Allergy Management
Oct 30, 2024 07:19AM Grip Security’s Market Leadership is Recognized Again as a Fortune ‘Cyber 60’ Company
Oct 30, 2024 07:17AM RTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facility
Oct 30, 2024 07:15AM Verisk Reports Third-Quarter 2024 Financial Results
Oct 30, 2024 07:10AM Lifeist Reports Third Quarter 2024 Financial Results
Oct 30, 2024 07:04AM Brunswick Exploration Discovers Greenland’s First Spodumene Pegmatite in Major Evolved Pegmatite Field
Oct 30, 2024 07:02AM Gilat Receives Approximately $5 Million in Orders from US Defense Customers
Oct 30, 2024 07:01AM Foresight Ventures Announces Strategic Partnership with Deep Blue and Arta TechFin to Enhance Stablecoin and RWA Business Initiatives
Oct 30, 2024 07:00AM Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Oct 30, 2024 07:00AM SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
Oct 30, 2024 07:00AM Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Oct 30, 2024 07:00AM Tecnoglass Named to Fortune's 100 Fastest-Growing Companies List
Oct 30, 2024 07:00AM The Chefs’ Warehouse Reports Third Quarter 2024 Financial Results
Oct 30, 2024 07:00AM Broadwind Announces Third Quarter 2024 Results Conference Call and Webcast Date
View Newer Stories View Older Stories